{"id":740,"date":"2022-10-31T06:12:00","date_gmt":"2022-10-31T11:12:00","guid":{"rendered":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/?p=740"},"modified":"2022-12-13T11:21:41","modified_gmt":"2022-12-13T17:21:41","slug":"u-s-to-begin-screening-air-passengers-from-uganda-for-ebola","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/2022\/10\/31\/u-s-to-begin-screening-air-passengers-from-uganda-for-ebola\/","title":{"rendered":"Response to Ebola Outbreak"},"content":{"rendered":"
\n

10\/31\/2022 Research successfully integrated into the Ebola outbreak response in Africa<\/strong><\/a> (Nature) Clinical trials conducted during Ebola outbreaks in Africa have been crucial in expanding the capacity to combat the disease. The latest Ebola outbreak in Uganda is expected to further improve knowledge on the disease, including testing new tools and vaccines.<\/p>\n\n\n\n

10\/27\/2022 Moderna Nears US Deal to Develop Shots for Ebola, Other Biological Threats<\/strong><\/a> (Bloomberg) Moderna Inc.\u00a0is close to clinching a deal with the US Department of Defense to develop\u00a0<\/em>messenger RNA vaccines targeting a range of biological threats such as Ebola virus. The contract will see Moderna work with researchers from the\u00a0University of Texas Medical Branch at Galveston<\/a>\u00a0to build on the company\u2019s mRNA technology that was used to rapidly make Covid-19 vaccines, according to people familiar with the situation who were not authorized to speak on the deal because it has not yet been finalized. Ebola has returned to the fore as a vaccine-resistant strain of the deadly virus spawned an outbreak in Uganda that began in September. \u00a0<\/p>\n\n\n\n

10\/26\/2022 Moderna Nears US Deal to Develop Shots for Ebola, Other Biological Threats<\/strong><\/a> (Bloomberg) Moderna Inc. is close to clinching a deal with the US Department of Defense to develop <\/em>messenger RNA vaccines targeting a range of biological threats such as Ebola virus.The contract will see Moderna work with researchers from the University of Texas Medical Branch at Galveston to build on the company\u2019s mRNA technology that was used to rapidly make Covid-19 vaccines, according to people familiar with the situation who were not authorized to speak on the deal because it has not yet been finalized. Ebola has returned to the fore as a vaccine-resistant strain of the deadly virus spawned an outbreak in Uganda that began in September.  <\/p>\n\n\n\n

10\/24\/2022 Merck locates frozen batch of undisclosed Ebola vaccine, will donate for testing in Uganda\u2019s outbreak<\/strong><\/a> After inquiries from Science, company confirms it produced and retains a candidate vaccine that could help bring the viral threat under control. In a revelation that may help Uganda combat its outbreak of Ebola, the pharmaceutical giant Merck has acknowledged to Science\u2014after repeated inquiries\u2014that it has up to 100,000 doses of an experimental vaccine for the deadly viral disease in its freezers in Pennsylvania and will donate them. The World Health Organization (WHO) and the Ugandan government are discussing whether and how these doses can be incorporated into one or more clinical trials of other candidate Ebola vaccines that could launch as soon as next month.<\/p>\n\n\n\n

10\/21\/12022 EU allocates emergency funding of \u20ac3 million to Uganda<\/strong><\/a> (European Commission) Following the outbreak of Ebola virus disease in Uganda, declared on September 2022, the EU has mobilised further emergency funding of \u20ac3 million to support the response to the outbreak. Part of this funding (\u20ac1.5 million) will support the World Health Organization in its coordination and surveillance activities, safe and dignified burials, as well as logistics and follow up and care of survivors.  \u20ac1 million will be allocated to UNICEF to address infection prevention and control, as well as risk communication and community engagement; while \u20ac500,000 will be allocated to the International Rescue Committee for preparedness and infection prevention and control in the most exposed refugee settlements.<\/p>\n\n\n\n

10\/21\/2022 Three ETUs\/Isolation Centers Stood Up in Kampala<\/strong> (NTV Uganda)<\/p>\n\n\n\n

\n